๐Ÿ‡บ๐Ÿ‡ธ FDA

Intelligence ยท Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors โ€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text โ€” searchable for business development and competitive intelligence.

14,283 results for โ€œBโ€ Clear

  1. Huangqi Guizhi Wuwu decoction

    The First People's Hospital of Lianyungang

    Diabetic Nephropathies

    small molecule active

    1 trial
  2. Human umbilical cord mesenchymal stem cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Knee Osteoarthritis

    mab active

    1 trial
  3. Hydrochloride anlotinib

    Zhongnan Hospital

    Uterine Cervical Neoplasms

    small molecule active

    1 trial
  4. Hydromorphone combined with ropivacaine

    Second Hospital of Jilin University

    Inguinal Hernia

    small molecule completed

    1 trial
  5. Hydroxychloroquine Sulfate 200 MG [Plaquenil]

    BRIGHT MINDS BIOSCIENCES INC.

    Coronavirus Infection

    small molecule completed

    1 trial
  6. Hydroxyurea

    United Therapeutics Europe Ltd

    Thrombocythemia

    small molecule completed

    1 trial
  7. Hypofractionated Radiation Therapy

    The First People's Hospital of Lianyungang

    Breast Cancer

    other active

    1 trial
  8. IMIQUIMOD cream 50mg/g

    BRIGHT MINDS BIOSCIENCES INC.

    Cutaneous Lupus Erythematosus

    small molecule active

    1 trial
  9. Ibuprofen

    United Therapeutics Europe Ltd

    Immune System and Related Disorders

    small molecule completed

    1 trial
  10. Immune-enhancing nutritional beverage

    United Therapeutics Europe Ltd

    Mitigation of Immune Function Decrements in Response to Stress

    other completed

    1 trial
  11. Indomethacin and Ibuprofen

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Ductus Arteriosus, Patent

    small molecule terminated

    1 trial
  12. Induction therapy-2 cycles of VPX (Teniposide, PD-1 monoclonal antibody plus Selinixor)

    The First People's Hospital of Lianyungang

    Primary Central Nervous System Lymphoma (PCNSL)

    small molecule active

    1 trial
  13. Induction therapy-3 cycles of BvC (Brentuximab vedotin plus Chidamide)

    The First People's Hospital of Lianyungang

    CD30+ Peripheral T-cell Lymphoma

    small molecule active

    1 trial
  14. Induction therapy-3 cycles of BvC (Brentuximab vedotin plus Chidamide)

    Hospital Authority, Hong Kong

    CD30+ Peripheral T-cell Lymphoma

    small molecule active

    1 trial
  15. Induction therapy-Pro regimen

    The First People's Hospital of Lianyungang

    Diffuse Large B-Cell Lymphoma

    small molecule active

    1 trial
  16. Infrared thermography

    The First People's Hospital of Lianyungang

    Chronic Obstructive Pulmonary Disease

    other active

    1 trial
  17. Inhaled Placebo

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Ventilator-Associated Pneumonia (VAP)

    small molecule active

    1 trial
  18. Inhaled corticosteriod/long-acting beta-agonist plus Montelukast

    Second Affiliated Hospital, School of Medicine, Zhejiang University

    Asthma

    small molecule active

    1 trial
  19. Insulin

    The First People's Hospital of Lianyungang

    Gestational Diabetes

    small molecule active

    1 trial
  20. Insulin

    United Therapeutics Europe Ltd

    Burns

    small molecule completed

    1 trial
  21. Insulin Aspart Injection๏ผˆUBLINยฎ๏ผ‰

    United Therapeutics Europe Ltd

    Pharmacokinetics and Pharmacodynamics

    small molecule active

    1 trial
  22. Intensive BP control

    Chinese University of Hong Kong

    Primary Hypertension

    small molecule active

    1 trial
  23. Intensive BP treatment group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypertension

    small molecule completed

    1 trial
  24. Interleukin-2

    The First People's Hospital of Lianyungang

    Beta Thalassemia Major

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1โ€“3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync โ€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources